Table 1.
Summary of NBP characteristics, extra- and intracellular ROS/RNS species, and involvement of molecules and signaling pathways in various biological samples of in vitro and in vivo NBP applications.
| Device type | Gas | OES | Extracellular RONS | Intracellular RONS | Scavenger | Cell | Effect | NBP-activated pathway or molecules | NBP-reduced effects | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|
| Jet | N2 | NO•, N2∗ | NO | NO | cPTIO | Osteoprogenitor cell line | Osteogenesis | ALP, COL-1 | — | [36] |
| Jet | He | O I, NO•, N2∗, O3 | — | NO | — | hPDL MSCs | Osteogenesis | ALP enzyme | [37] | |
| Jet | N2 | NO•, N2∗, O2+ | — | — | — | Animal | Myogenesis | p38, MYH3, MHC, MypG, MyoD | — | [38] |
| Jet | He + 1%O2 | •OH, O2∗, O, NO | NO | NO | Hgb | Murine-immortalized neural stem cell line C17.2 Primary rat neural stem cells (isolated from the hippocampus) |
Neurogenesis | β-Tublin III, APC, | Nestin | [39] |
| Jet | He | •OH, •O2− | H2O2 | — | — | Osteoprogenitor cells (MC3T3-E1 cell line) | Osteogenesis | ALP enzyme, ALP, OCN | — | [40] |
| DBD | Air | — | H2O2 | H2O2, O2•- | NAC, TEMPOL | Preosteocytic cell line (MLO-A5); N1511 chondrocyte cell line | Osteogenesis & chondrogenesis | — | — | [35] |
| DBD | N2 | NO•, N2∗,•OH | H2O2, NO | — | — | Osteoprogenitor cell line | Osteogenesis | p38, FoxO1 | — | [46] |
| DBD | N2 and air | Excited O I | NO | O2•- (mitochondrial), H2O2 (cytosolic) | MitoTEMPO− Trolox, NAC− | Mouse neuroblastoma Neuro 2A | Neurogenesis | ERK, Trk, Ras | — | [55] |
| DBD | He | ROS RNS | — | ROS NO | BHA | Human adipose tissue-derived stem cells (ASCs) | Proliferation | AKT, ERK, NF-κB | — | [47] |
| Jet | Air | •OH, O I, N2∗ | O2−, •OH, H2O2 | •OH, H2O2 | Mannitol, catalase and sodium pyruvate | Brain and lung cancer cell lines | Apoptosis | ERK Bak, bax, caspase,H2AX, | bcl-2 | [82] |
| DBD | He | — | — | — | — | Cervical cancer cell line | Inhibition of migration | — | MMP9 ERK, JNK (cell migration) | [52] |
| Jet | He + O2 | •OH, O∗, O+ (~1013/m3 ROS density) | — | Total ROS | NAC | Head and neck cancer cells | Apoptosis | JNK, p38, caspase 3 | Migration invasion | [78] |
| Jet | He + O2 | •OH, O∗, O+ | — | Total ROS | NAC | Colorectal cancer cell | Apoptosis | p38, JNK, ERK, β-catenin | Cyclin D1 | [79] |
| Jet | He + O2 | O I, NO•, O+ FNS, N2∗, •OH | — | Total ROS | NAC | Thyroid cancer cell | Apoptosis | JNK, p38, caspase 3 | — | [43] |
| Jet | Air | H2O2, Ox, OH−, •O2, NOx | H2O2, NO | H2O2, NO | NAC cPTIO | Cervical cancer cells | Apoptosis | JNK, p38 | — | [80] |
| Jet | He | •OH, N2∗, O I | — | Total ROS, NO | NAC | Melanoma cancer cells | Apoptosis | TNF, ASK-1, JNK, p38 r-H2AX, casp3/7 | — | [81] |
| Jet | Ar | •OH, O I, NO, N2∗ | H2O2 | — | NAC | Ovarian cancer cell, human primary mesothelial cells, BALB/C mice | Cancer cell migration | — | MMP9 inhibits JNK and p38 | [53] |
| Jet | Ar | — | H2O2 | — | — | Immune cell lines | — | ERK, p38, JNK HSP27 (THP-1) | — | [83] |
| Jet | Air | — | — | Total ROS | NAC catalase | Breast carcinoma | Apoptosis | PTEN | pAKT, STAT3 pathway, IL-6R pathway | [92] |
| DBD | Air | •OH, O I, N2∗ | — | Total ROS | NAC | Glioblastoma and lung adenocarcinoma cell lines, BALB/c mice | Migration, growth | E-cadherin (epithelial maker) | PI3K/Akt, N-cadherin, Slug, Zeb-1 | [102] |
| Jet | He and O2 | ROS density with ~1013/m3 | — | Total ROS | NAC | Head and neck cancer cell lines | Growth inhibition | — | Akt degradation | [94] |